SEC Form 4 · accession 0001472595-16-000150
R1 RCM INC. · RCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John B Henneman III
Director
Period of report
Feb 22, 2016
Accepted (ET)
Feb 24, 2016 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472595
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F2,F1 | $2.61 | Feb 22, 2016 | A | 405,111 | A | — | Feb 22, 2026 | Common Stock | 405,111 | 405,111 | D |
Explanation of responses
- F1The option vests in four equal annual installments beginning on February 22, 2017 based on continued service as a director.
- F2The option was issued to the reporting person pursuant to the Accretive Health director compensation plan.